Ginkgo Bioworks Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	121.84	170.16	227.04	251.46	477.71	313.84
Revenue Growth (YoY)	-35.57%	-25.06%	-9.71%	-47.36%	52.22%	309.40%
Cost of Revenue	32.08	46.97	44.55	54.01	204.22	129.69
Gross Profit	89.76	123.18	182.5	197.45	273.49	184.15
Selling, General & Admin	172.08	183.29	246.16	385.03	1,430	862.95
Research & Development	222.77	243.77	424.06	580.62	1,053	1,150
Other Operating Expenses	6.13	11.4	72.03	96.21	-	-
Total Operating Expenses	400.97	438.46	742.25	1,062	2,482	2,013
Operating Income	-297.68	-315.28	-559.76	-864.41	-2,209	-1,828
Interest Income	-	22.62	38.61	57.22	20.26	0.84
Interest Expense	-	-	-0.09	-0.09	-0.11	-2.37
Other Non-Operating Income (Expense)	4.03	-20.94	-26.27	-85.66	67.4	-8.12
Total Non-Operating Income (Expense)	4.03	1.68	12.25	-28.53	87.55	-9.66
Pretax Income	-298.87	-313.6	-547.51	-892.94	-2,121	-1,838
Provision for Income Taxes	-1.01	-0.84	-0.48	-0.07	-15.03	-1.48
Net Income	-386.98	-312.76	-547.03	-892.87	-2,105	-1,830
Minority Interest in Earnings	-	-	-	-	-1.44	-6.6
Earnings From Discontinued Operations	-6.53	-	-	-	-	-
Net Income to Common	-386.98	-312.76	-547.03	-892.87	-2,105	-1,830
Shares Outstanding (Basic)	57	55	52	49	42	34
Shares Outstanding (Diluted)	57	55	52	49	42	34
Shares Change (YoY)	7.30%	6.87%	6.76%	15.75%	23.48%	6.71%
EPS (Basic)	-5.36	-5.64	-10.54	-18.37	-50.00	-54.00
EPS (Diluted)	-5.36	-5.64	-10.54	-18.37	-50.00	-55.60
Shares Outstanding	61.66	55.21	51.37	50.03	47.3	40.28
Free Cash Flow	-168.2	-178.72	-382.13	-336.3	-304.47	-310.34
Free Cash Flow Per Share	-2.96	-3.22	-7.36	-6.92	-7.25	-9.13
Gross Margin	73.67%	72.39%	80.38%	78.52%	57.25%	58.68%
Operating Margin	-244.33%	-185.29%	-246.54%	-343.76%	-462.41%	-582.62%
Profit Margin	-312.26%	-183.81%	-240.94%	-355.08%	-440.94%	-585.22%
FCF Margin	-138.05%	-105.04%	-168.31%	-133.74%	-63.74%	-98.89%
EBITDA	-241.26	-256.29	-496.74	-793.9	-2,166	-1,799
EBITDA Margin	-198.02%	-150.62%	-218.78%	-315.72%	-453.50%	-573.35%
EBIT	-297.68	-315.28	-559.76	-864.41	-2,209	-1,828
EBIT Margin	-244.33%	-185.29%	-246.54%	-343.76%	-462.41%	-582.62%
Effective Tax Rate	0.34%	0.27%	0.09%	0.01%	0.71%	0.08%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q